Northwire Canada EditionFriday, July 10, 2026
Northwire
NNX 0.035 +0.0% ABX 51.92 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.70 +9.1% TUNG 1.74 +3.0% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.49 +0.9% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.305 −4.7% DEX 0.390 +1.3% WMS 0.040 +0.0% NNX 0.035 +0.0% ABX 51.92 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.70 +9.1% TUNG 1.74 +3.0% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.49 +0.9% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.305 −4.7% DEX 0.390 +1.3% WMS 0.040 +0.0%
Financings Routine −

DELPHX ANNOUNCES NON-BROKERED PRIVATE PLACEMENT

DelphX Capital Markets Struggles to Secure Strategic Debt Amidst Continuous Equity Dilution

Executive Summary
  • Latest Financing: On April 22, 2026, DelphX announced a non-brokered private placement of up to 3,750,000 units at C$0.04 per unit, targeting gross proceeds of C$150,000.
  • Unit Structure: Each unit comprises one common share and one warrant exercisable at C$0.08 for two years.
  • Use of Proceeds: General corporate purposes (working capital).
  • Regulatory Status: Subject to TSX Venture Exchange approval with a four-month hold period on securities.
  • Contextual Progression: This follows a March 24, 2026 update where the company claimed "final-stage talks" for a USD $18 million convertible debenture and a senior secured loan for its Bitcoin treasury program. The April announcement contradicts the momentum of that larger financing by resorting to a minimal equity raise.
  • Historical Pattern: This is part of a recurring cycle of small private placements throughout late 2025 and early 2026 (ranging from C$50,000 to C$250,000), indicating persistent liquidity constraints rather than strategic growth financing.
Material Impact
  • Dilution Risk: The issuance of 3.75 million units at the current market price ($0.04) represents immediate dilution without a corresponding increase in asset value or revenue. Given the company's repeated reliance on equity for working capital, shareholder value is being eroded incrementally.
  • Execution Credibility: The March 24 news highlighted significant institutional financing talks (USD $18m debenture + senior loan). The April 22 tiny raise suggests these larger deals have stalled or failed to materialize, forcing the company back into survival mode. This discrepancy creates a credibility gap regarding management's ability to execute strategic capital raises.
  • Warrant Overhang: New warrants issued at C$0.08 (double the current price) add future dilution pressure. Combined with existing warrants from previous rounds (exercise prices ranging $0.06 to $0.15), the fully diluted share count is significantly higher than the outstanding common shares, suppressing upside potential.
  • Capital Efficiency: Raising C$150,000 for "general corporate purposes" while claiming a USD $50 million Bitcoin treasury strategy indicates a severe mismatch between ambition and available capital resources. The company lacks the liquidity to fund its own stated strategic initiatives without further external financing.
DELX · Price
Company Overview
  • Core Business: DelphX Capital Markets Inc. positions itself as a blockchain-based financial innovation firm.
  • Flagship Product: Quantem Crypto Securities (QCS), described as a collateralized hedging solution for institutional Bitcoin treasuries to mitigate volatility risk.
  • Treasury Strategy: The company aims to build its own Bitcoin treasury, targeting USD $50 million acquisition via monthly tranches using proprietary QCS platform and structured financing.
  • Development Status: As of April 2026, the QCS product is in "proof-of-concept" or early due diligence stages with potential partners (e.g., Belgravia Hartford Capital). No commercial revenue has been disclosed from these initiatives.
Read the original news release →

More from DelphX Capital Markets Inc.